STOCK TITAN

Omega Healthcare Financials

OHI
Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Omega Healthcare (OHI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 18 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI OHI FY2025

Omega Healthcare’s core mechanic is converting asset income into operating cash that is largely distributed while leverage falls.

The most revealing FY2025 combination is tighter liquidity but better solvency: cash fell to $27M from $518M. Yet debt-to-equity improved from 1.1x to 0.8x, showing current cash generation is being used to reshape the balance sheet rather than to build a cash buffer, so short-term flexibility narrowed even as leverage improved.

In FY2025, dividends of $780M consumed most of operating cash flow of $879M. That leaves little internally generated cash for rebuilding liquidity after investing outflows, which is why the business behaves like a cash pass-through and why distribution policy strongly influences balance-sheet flexibility.

Long-term debt was $4.26B in FY2025 versus $5.25B in FY2021, a clear deleveraging trend rather than a one-year swing. Interest expense also eased to $215M from $235M, so the balance-sheet repair is starting to reduce the business’s fixed cash claims.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 25 / 100
Financial Profile 25/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Omega Healthcare's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth
53

Omega Healthcare's revenue grew 13.2% year-over-year to $1.2B, a solid pace of expansion. This earns a growth score of 53/100.

Leverage
85

Omega Healthcare carries a low D/E ratio of 0.82, meaning only $0.82 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 85/100, indicating a strong balance sheet with room for future borrowing.

Returns
11

Omega Healthcare generates a 0.0% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 11/100. This is up from 0.0% the prior year.

Piotroski F-Score Neutral
6/9

Omega Healthcare passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed
1441.51x

For every $1 of reported earnings, Omega Healthcare generates $1441.51 in operating cash flow ($878.6M OCF vs $609K net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$1.2B
YoY+13.2%
5Y CAGR+5.9%

Omega Healthcare generated $1.2B in revenue in fiscal year 2025. This represents an increase of 13.2% from the prior year.

EBITDA
N/A
Net Income
$609K
YoY+45.9%
5Y CAGR-67.3%
10Y CAGR-44.8%

Omega Healthcare reported $609K in net income in fiscal year 2025. This represents an increase of 45.9% from the prior year.

EPS (Diluted)
$1.94
YoY+25.2%
5Y CAGR+22.6%
10Y CAGR+4.2%

Omega Healthcare earned $1.94 per diluted share (EPS) in fiscal year 2025. This represents an increase of 25.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$27.0M
YoY-94.8%
5Y CAGR-30.2%
10Y CAGR+17.4%

Omega Healthcare held $27.0M in cash against $4.3B in long-term debt as of fiscal year 2025.

Dividends Per Share
$2.68
YoY+0.0%
5Y CAGR+0.0%
10Y CAGR+2.1%

Omega Healthcare paid $2.68 per share in dividends in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Shares Outstanding
296M
YoY+4.9%
5Y CAGR+5.0%
10Y CAGR+4.7%

Omega Healthcare had 296M shares outstanding in fiscal year 2025. This represents an increase of 4.9% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
0.1%
YoY+0.0pp
5Y CAGR-18.3pp

Omega Healthcare's net profit margin was 0.1% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.0 percentage points from the prior year.

Return on Equity
0.0%
YoY+0.0pp
5Y CAGR-4.3pp
10Y CAGR-6.2pp

Omega Healthcare's ROE was 0.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.0 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

OHI Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $323.0M+1.2% $319.2M+2.4% $311.6M+10.3% $282.5M+2.1% $276.8M-0.9% $279.3M+1.2% $276.0M+9.2% $252.7M
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $26.0M+6.4% $24.5M+2.9% $23.8M-0.3% $23.8M-25.6% $32.1M+42.1% $22.6M+3.7% $21.8M-1.8% $22.1M
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense $49.8M-3.8% $51.7M-11.0% $58.1M+9.9% $52.9M+1.2% $52.3M-5.4% $55.2M+1.0% $54.7M+1.3% $54.0M
Income Tax $5.1M+140.2% $2.1M-52.6% $4.5M-1.0% $4.5M+25.4% $3.6M+21.1% $3.0M-10.1% $3.3M+67.5% $2.0M
Net Income $151.0M+135.6% -$424.7M-336.3% $179.7M+31.6% $136.6M+25.3% $109.0M+137.3% -$292.6M-361.8% $111.8M-1.8% $113.9M
EPS (Diluted) $0.47 N/A $0.59+28.3% $0.46+39.4% $0.33 N/A $0.42-6.7% $0.45

OHI Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $10.2B+1.8% $10.0B-5.2% $10.6B+0.5% $10.5B+8.7% $9.7B-1.9% $9.9B+3.4% $9.6B+8.2% $8.8B
Current Assets N/A N/A N/A N/A N/A N/A N/A N/A
Cash & Equivalents $26.1M-3.2% $27.0M-96.3% $737.2M+0.4% $734.2M+99.5% $368.0M-29.0% $518.3M+51.4% $342.4M+873.0% $35.2M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill $644.4M0.0% $644.6M0.0% $644.6M0.0% $644.9M+0.1% $644.1M+0.1% $643.7M-0.1% $644.6M+0.1% $643.8M
Total Liabilities $4.8B+3.7% $4.6B-13.9% $5.4B-0.1% $5.4B+12.2% $4.8B-7.6% $5.2B-0.1% $5.2B+4.5% $4.9B
Current Liabilities N/A N/A N/A N/A N/A N/A N/A N/A
Long-Term Debt N/A $4.3B-14.8% $5.0B-0.1% $5.0B+12.5% $4.4B-8.1% $4.8B-0.4% $4.9B+4.2% $4.7B
Total Equity $5.2B+0.2% $5.2B+2.9% $5.0B+1.0% $5.0B+5.2% $4.7B+4.5% $4.5B+7.8% $4.2B+13.4% $3.7B
Retained Earnings $4.8B+3.2% $4.7B+3.7% $4.5B+4.1% $4.3B+3.3% $4.2B+2.7% $4.1B+2.9% $4.0B+2.9% $3.9B

OHI Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow $215.5M-6.6% $230.6M+1.7% $226.7M-5.2% $239.3M+31.5% $182.0M-20.5% $229.0M+23.8% $184.9M+0.4% $184.1M
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow -$270.0M-2206.4% -$11.7M+86.0% -$83.8M+81.9% -$463.5M-2506.7% $19.3M+106.8% -$281.7M-111.1% -$133.5M+36.0% -$208.5M
Financing Cash Flow $54.3M+105.8% -$940.5M-576.3% -$139.1M-123.6% $589.0M+269.4% -$347.7M-242.8% $243.4M-9.2% $268.1M+189.6% -$299.2M
Dividends Paid $198.4M0.0% $198.4M+0.1% $198.2M+1.9% $194.6M+2.8% $189.2M+4.3% $181.4M+4.7% $173.3M+4.4% $166.0M
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

OHI Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin 46.8%+179.8pp -133.1%-190.7pp 57.7%+9.3pp 48.4%+9.0pp 39.4%+144.1pp -104.7%-145.2pp 40.5%-4.6pp 45.1%
Return on Equity 2.9%+11.1pp -8.2%-11.8pp 3.6%+0.8pp 2.7%+0.4pp 2.3%+8.7pp -6.4%-9.1pp 2.7%-0.4pp 3.1%
Return on Assets 1.5%+5.7pp -4.2%-5.9pp 1.7%+0.4pp 1.3%+0.2pp 1.1%+4.1pp -3.0%-4.1pp 1.2%-0.1pp 1.3%
Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
Debt-to-Equity 0.92+0.1 0.82-0.2 0.99-0.0 1.00+0.1 0.94-0.1 1.07-0.1 1.15-0.1 1.26
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Similar Companies

Frequently Asked Questions

Omega Healthcare (OHI) reported $1.2B in total revenue for fiscal year 2025. This represents a 13.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Omega Healthcare (OHI) revenue grew by 13.2% year-over-year, from $1.1B to $1.2B in fiscal year 2025.

Yes, Omega Healthcare (OHI) reported a net income of $609K in fiscal year 2025, with a net profit margin of 0.1%.

Omega Healthcare (OHI) reported diluted earnings per share of $1.94 for fiscal year 2025. This represents a 25.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, Omega Healthcare (OHI) had $27.0M in cash and equivalents against $4.3B in long-term debt.

Omega Healthcare (OHI) had a net profit margin of 0.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Omega Healthcare (OHI) paid $2.68 per share in dividends during fiscal year 2025.

Omega Healthcare (OHI) has a return on equity of 0.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Omega Healthcare (OHI) generated $878.6M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Omega Healthcare (OHI) had $10.0B in total assets as of fiscal year 2025, including both current and long-term assets.

Omega Healthcare (OHI) had 296M shares outstanding as of fiscal year 2025.

Omega Healthcare (OHI) had a debt-to-equity ratio of 0.82 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Omega Healthcare (OHI) had a return on assets of 0.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Omega Healthcare (OHI) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Omega Healthcare (OHI) has an earnings quality ratio of 1441.51x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Omega Healthcare (OHI) scores 25 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top